tiprankstipranks
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
US Market
CAPR
Capricor Therapeutics
RESEARCH TOOLSreports
Want to see CAPR full AI Analyst Report?

Capricor Therapeutics (CAPR) Income Statement

1,294 Followers

Capricor Therapeutics Income Statement

Last quarter (Q4 2025), Capricor Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Capricor Therapeutics's net income was $-30.17M. See Capricor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 22.27M$ 25.18M$ 2.55M$ 244.90K
Gross Profit
$ 0.00$ -27.70M$ -11.27M$ -19.27M$ 244.90K
Operating Expenses
$ 108.14M$ 14.87M$ 12.81M$ 10.43M$ 21.18M
Depreciation and Amortization
$ 0.00$ 1.43M$ 1.07M$ 533.13K$ 245.70K
EBITDA
$ -108.14M$ -41.14M$ -23.01M$ -29.16M$ -20.69M
Operating Income
$ -108.14M$ -42.56M$ -24.08M$ -29.70M$ -20.94M
Other Income/Expenses
$ 3.10M$ 2.10M$ 1.79M$ 677.85K$ 915.92K
Pretax Income
$ -105.04M$ -40.47M$ -22.29M$ -29.02M$ -20.02M
Net Income
$ -105.04M$ -40.47M$ -22.29M$ -29.02M$ -20.02M
Per Share Metrics
Basic EPS
$ -2.26$ -1.15$ -0.83$ -1.18$ -0.87
Diluted EPS
$ -2.26$ -1.15$ -0.83$ -1.18$ -0.87
Weighted Average Shares Outstanding
 46.48M 35.22M 26.78M 24.55M 23.09M
Weighted Average Shares Outstanding (Diluted)
 46.48M 35.22M 26.78M 24.55M 23.09M
Currency in USD

Capricor Therapeutics Earnings and Revenue History